To evaluate and compare the in-vivo safety and efficacy of three skin care formulations versus Untreated control in terms of the moisturization effect on healthy human subjects. - NI

Dabur India Ltd.0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

试验速览

暂无简介。

•1)Skin is healthy on the studied anatomic unit (free of eczema, wounds, inflammatory scar….)
•2)Subject having dry skin on forearms

•1)For female: Being pregnant or breastfeeding or having stopped to breastfeed in the past three months.Having refused to give her assent by signing the consent form.
•2)Taking part in another study liable to interfere with this study.
•3)Being known diabetic case
•4)Known asthma case
•5)Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area (except for specific studies on a determined dermatosis)
•6)Being known thyroid case
•7)Being epileptic.
•8)Following a chronic medicinal treatment comprising any of the following product: aspirin-based product, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes or corticosteroid by any route (the only medication permitted is paracetamol)
•9)Known case of hypersensitivity.
•10)Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic product.
•11)Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
•12)Having changed their cosmetic habits except those required by the protocol in the 14 days preceding the start of the study on the studied anatomic unit.
•13)Having applied a cosmetic product (included make-up) on the studied areas 48 hours prior study.

发起方